These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 87476)

  • 1. Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization.
    Chapes SK; Tompkins WA
    J Immunol; 1979 Jul; 123(1):303-10. PubMed ID: 87476
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H; Tompkins WA
    J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to acute virus infection in the Syrian hamster. II. Studies on the identity of virus-induced cytotoxic effector cells.
    Nelles MJ; Duncan WR; Streilein JW
    J Immunol; 1981 Jan; 126(1):214-8. PubMed ID: 7005334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets.
    Piontek GE; Weltzin R; Tompkins WA
    J Reticuloendothel Soc; 1980 Feb; 27(2):175-88. PubMed ID: 6244409
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S; Nozima T
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus.
    Issekutz TB
    Clin Exp Immunol; 1984 Jun; 56(3):515-23. PubMed ID: 6204794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural killer cell cytotoxicity from bone marrow cells cocultivated with immune peritoneal macrophages.
    Chapes SK; Fan SS; Cummins JM; Tompkins WA
    J Reticuloendothel Soc; 1981 May; 29(5):341-55. PubMed ID: 6165823
    [No Abstract]   [Full Text] [Related]  

  • 8. The response of gut-associated T lymphocytes to intestinal viral immunization.
    Issekutz TB
    J Immunol; 1984 Dec; 133(6):2955-60. PubMed ID: 6333450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    Schultz RM; Woan MC; Tompkins WA
    J Reticuloendothel Soc; 1974 Jul; 16(1):37-47. PubMed ID: 4137839
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activated macrophages: effector cells of antitumor protection].
    Viadro MM
    Vopr Onkol; 1981; 27(6):80-9. PubMed ID: 7023041
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of syngeneic tumor growth in vaccinia virus-primed mice by immunization with vaccinia virus-modulated tumor cells.
    Wu KS; Ueda S; Sakaue Y; Ohashi Y; Ikuta K; Sugano T; Kato S
    Biken J; 1981 Dec; 24(4):153-8. PubMed ID: 7346041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
    Tompkins MB; Tompkins WA
    J Immunol; 1985 Oct; 135(4):2817-23. PubMed ID: 2993416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats.
    Zinkernagel RM; Althage A; Jensen FC
    J Immunol; 1977 Oct; 119(4):1242-7. PubMed ID: 408419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble antigens of vaccinia virus. Note I. Chemical and biological properties. Immunogenic capacity.
    Mihăilescu R; Olinescu A; Popa L; Stavri H; Iancu L
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):35-46. PubMed ID: 2449147
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen.
    Acres RB; Hareuveni M; Balloul JM; Kieny MP
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):136-43. PubMed ID: 8280702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vaccinia-activated macrophages on scrapie infection in hamsters.
    Marsh RF
    Adv Exp Med Biol; 1981; 134():359-63. PubMed ID: 7194567
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus-specific cytolytic cells. Their in vivo function.
    Finberg R; Ertl HC; Shapiro ME
    Surv Immunol Res; 1982; 1(3):248-54. PubMed ID: 6195715
    [No Abstract]   [Full Text] [Related]  

  • 19. Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young mice.
    Schwartz DH; Doherty PC
    J Immunol; 1981 Oct; 127(4):1411-4. PubMed ID: 6974190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pathogenesis of postvaccinal complications].
    Huber HC
    Fortschr Med; 1981 Mar; 99(11):380-1. PubMed ID: 6112195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.